Breaking News Instant updates and real-time market news.

STWRY

Software AG

$0.00 /

+ (+0.00%)

14:38
01/13/21
01/13
14:38
01/13/21
14:38

Software AG price target lowered to EUR 35 from EUR 37 at JPMorgan

JPMorgan analyst Stacy Pollard lowered the firm's price target on Software AG to EUR 35 from EUR 37 and keeps a Neutral rating on the shares.

STWRY Software AG
$0.00 /

+ (+0.00%)

12/14/20 Societe Generale
Software AG price target lowered to EUR 30 from EUR 32 at Societe Generale
12/11/20 Societe Generale
Software AG price target lowered to EUR 30 from EUR 32 at Societe Generale
12/08/20 Kepler Cheuvreux
Software AG downgraded to Hold from Buy at Kepler Cheuvreux
10/23/20 Deutsche Bank
Software AG price target lowered to EUR 33 from EUR 36 at Deutsche Bank

TODAY'S FREE FLY STORIES

Initiation
LoanDepot initiated with a Neutral at Goldman Sachs » 05:02
03/08/21
03/08
05:02
03/08/21
05:02
LDI

LoanDepot

$18.55 /

+0.33 (+1.81%)

, RKT

Rocket Companies

$25.07 /

-1.7801 (-6.63%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LDI LoanDepot
$18.55 /

+0.33 (+1.81%)

RKT Rocket Companies
$25.07 /

-1.7801 (-6.63%)

LDI LoanDepot
$18.55 /

+0.33 (+1.81%)

RKT Rocket Companies
$25.07 /

-1.7801 (-6.63%)

03/03/21
Fly Intel: Top five analyst downgrades
03/03/21 Zelman
Rocket Companies downgraded to Hold from Buy at Zelman
03/02/21 RBC Capital
Rocket Companies downgraded to Sector Perform from Outperform at RBC Capital
03/02/21 Wells Fargo
Wells says Rocket Companies Q4 results 'not good enough to support' today's move
RKT Rocket Companies
$25.07 /

-1.7801 (-6.63%)

  • 11
    Feb
  • 06
    Aug
RKT Rocket Companies
$25.07 /

-1.7801 (-6.63%)

LDI LoanDepot
$18.55 /

+0.33 (+1.81%)

RKT Rocket Companies
$25.07 /

-1.7801 (-6.63%)

RKT Rocket Companies
$25.07 /

-1.7801 (-6.63%)

Initiation
Bioventus initiated with a Buy at Goldman Sachs » 05:00
03/08/21
03/08
05:00
03/08/21
05:00
BVS

Bioventus

$11.50 /

-0.48 (-4.01%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
  • 11
    Feb
BVS Bioventus
$11.50 /

-0.48 (-4.01%)

Initiation
Bumble initiated with a Market Perform at BMO Capital » 04:59
03/08/21
03/08
04:59
03/08/21
04:59
BMBL

Bumble

$61.93 /

+2.41 (+4.05%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMBL Bumble
$61.93 /

+2.41 (+4.05%)

03/04/21
Fly Intel: Top five analyst initiations
03/04/21 Susquehanna
Bumble initiated with a Positive, $78 price target at Susquehanna
03/04/21 Susquehanna
Bumble initiated with a Positive at Susquehanna
03/02/21 Benchmark
Benchmark sees 'hidden asset' inside Momo, ups target to $32
  • 11
    Feb
BMBL Bumble
$61.93 /

+2.41 (+4.05%)

BMBL Bumble
$61.93 /

+2.41 (+4.05%)

Initiation
Nuvation Bio initiated with an Outperform at BMO Capital » 04:57
03/08/21
03/08
04:57
03/08/21
04:57
NUVB

Nuvation Bio

$10.86 /

+0.36 (+3.43%)

BMO Capital analyst Do…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Upgrade
Marvell upgraded to Outperform from Market Perform at BMO Capital » 04:56
03/08/21
03/08
04:56
03/08/21
04:56
MRVL

Marvell

$41.51 /

+1.41 (+3.52%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
$41.51 /

+1.41 (+3.52%)

MRVL Marvell
$41.51 /

+1.41 (+3.52%)

03/04/21 Jefferies
Marvell long-term visibility better than previously thought, says Jefferies
03/02/21 Susquehanna
Marvell results expected to be a modest beat, says Susquehanna
02/16/21 Needham
Inphi price target raised to $191 from $175 at Needham
02/09/21 Barclays
Inphi downgraded to Equal Weight on Marvell deal at Barclays
MRVL Marvell
$41.51 /

+1.41 (+3.52%)

MRVL Marvell
$41.51 /

+1.41 (+3.52%)

MRVL Marvell
$41.51 /

+1.41 (+3.52%)

MRVL Marvell
$41.51 /

+1.41 (+3.52%)

General news
3-Month Bill Auction to be released at 11:30  04:55
03/08/21
03/08
04:55
03/08/21
04:55
 
General news
6-Month Bill Auction to be released at 11:30  04:55
03/08/21
03/08
04:55
03/08/21
04:55
 
Conference/Events
Atlassian management to meet virtually with Mizuho » 04:55
03/08/21
03/08
04:55
03/08/21
04:55
TEAM

Atlassian

$228.22 /

+2.865 (+1.27%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TEAM Atlassian
$228.22 /

+2.865 (+1.27%)

TEAM Atlassian
$228.22 /

+2.865 (+1.27%)

03/03/21 Citi
Atlassian assumed with a Buy at Citi
01/29/21 DA Davidson
Atlassian price target raised to $275 from $235 at DA Davidson
01/29/21 BMO Capital
Atlassian price target raised to $260 from $235 at BMO Capital
01/29/21 Canaccord
Atlassian price target raised to $260 from $225 at Canaccord
TEAM Atlassian
$228.22 /

+2.865 (+1.27%)

TEAM Atlassian
$228.22 /

+2.865 (+1.27%)

TEAM Atlassian
$228.22 /

+2.865 (+1.27%)

Conference/Events
Oppenheimer healthcare analysts hold an analyst/industry conference call » 04:55
03/08/21
03/08
04:55
03/08/21
04:55

Healthcare Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Jamf Holding management to meet virtually with Mizuho » 04:55
03/08/21
03/08
04:55
03/08/21
04:55
JAMF

Jamf Holding

$35.02 /

-1.435 (-3.94%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JAMF Jamf Holding
$35.02 /

-1.435 (-3.94%)

JAMF Jamf Holding
$35.02 /

-1.435 (-3.94%)

03/05/21 RBC Capital
Jamf Holding price target raised to $49 from $45 at RBC Capital
03/05/21 Mizuho
Jamf Holding price target raised to $45 from $43 at Mizuho
01/28/21 Piper Sandler
Jamf Holding remains a top idea for 2021 at Piper Sandler
01/05/21 Canaccord
Jamf Holding metrics 'bode well' for strong Q4, says Canaccord
JAMF Jamf Holding
$35.02 /

-1.435 (-3.94%)

  • 19
    Nov
  • 22
    Jul
JAMF Jamf Holding
$35.02 /

-1.435 (-3.94%)

Conference/Events
Amicus participates in a conference call with JPMorgan » 04:55
03/08/21
03/08
04:55
03/08/21
04:55
FOLD

Amicus

$10.50 /

+0.15 (+1.45%)

SMid Cap Biotech Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FOLD Amicus
$10.50 /

+0.15 (+1.45%)

FOLD Amicus
$10.50 /

+0.15 (+1.45%)

03/01/21 Stifel
Amicus initiated with a Hold at Stifel
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
FOLD Amicus
$10.50 /

+0.15 (+1.45%)

FOLD Amicus
$10.50 /

+0.15 (+1.45%)

FOLD Amicus
$10.50 /

+0.15 (+1.45%)

FOLD Amicus
$10.50 /

+0.15 (+1.45%)

Conference/Events
Ritchie Bros. management to meet virtually with Barrington » 04:55
03/08/21
03/08
04:55
03/08/21
04:55
RBA

Ritchie Bros.

$54.35 /

+3.2 (+6.26%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RBA Ritchie Bros.
$54.35 /

+3.2 (+6.26%)

RBA Ritchie Bros.
$54.35 /

+3.2 (+6.26%)

02/24/21
Fly Intel: Top five analyst upgrades
02/24/21 National Bank
Ritchie Bros. upgraded to Outperform from Sector Perform at National Bank
02/04/21 BofA
Ritchie Bros. downgraded to Underperform on cyclical headwinds at BofA
02/04/21 BofA
Ritchie Bros. downgraded to Underperform from Neutral at BofA
RBA Ritchie Bros.
$54.35 /

+3.2 (+6.26%)

Conference/Events
Ideaya Biosciences management to meet virtually with Wedbush » 04:55
03/08/21
03/08
04:55
03/08/21
04:55
IDYA

Ideaya Biosciences

$19.95 /

+0.99 (+5.22%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IDYA Ideaya Biosciences
$19.95 /

+0.99 (+5.22%)

IDYA Ideaya Biosciences
$19.95 /

+0.99 (+5.22%)

01/29/21 Baird
Ideaya Biosciences assumed at Outperform at Baird
01/06/21 Northland
Ideaya Biosciences named a top pick in small cap biotech at Northland
01/05/21 Roth Capital
Ideaya combo trial opens up large opportunity, says Roth Capital
10/06/20 Wedbush
Wedbush starts Ideaya Biosciences at Outperform with $21 price target
IDYA Ideaya Biosciences
$19.95 /

+0.99 (+5.22%)

  • 18
    Jun
General news
Wholesale Inventories (Preliminary) Month over Month to be reported at 10:00 » 04:55
03/08/21
03/08
04:55
03/08/21
04:55

January Wholesale…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Silvergate Capital management to meet virtually with Compass Point » 04:55
03/08/21
03/08
04:55
03/08/21
04:55
SI

Silvergate Capital

$106.63 /

-11.01 (-9.36%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SI Silvergate Capital
$106.63 /

-11.01 (-9.36%)

SI Silvergate Capital
$106.63 /

-11.01 (-9.36%)

03/02/21 Wedbush
Silvergate Capital price target raised to $175 from $150 at Wedbush
02/04/21 Craig-Hallum
Silvergate Capital price target raised to $135 from $80 at Craig-Hallum
01/25/21 Canaccord
Silvergate Capital price target raised to $90 from $40 at Canaccord
01/25/21 Barclays
Silvergate Capital price target raised to $85 from $76 at Barclays
SI Silvergate Capital
$106.63 /

-11.01 (-9.36%)

  • 22
    Jan
SI Silvergate Capital
$106.63 /

-11.01 (-9.36%)

SI Silvergate Capital
$106.63 /

-11.01 (-9.36%)

SI Silvergate Capital
$106.63 /

-11.01 (-9.36%)

Conference/Events
Prestige Consumer management to meet virtually with Sidoti » 04:55
03/08/21
03/08
04:55
03/08/21
04:55
PBH

Prestige Consumer

$43.52 /

+0.93 (+2.18%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PBH Prestige Consumer
$43.52 /

+0.93 (+2.18%)

PBH Prestige Consumer
$43.52 /

+0.93 (+2.18%)

08/07/20 DA Davidson
Prestige Consumer downgraded to Neutral from Buy at DA Davidson
08/07/20 DA Davidson
Prestige Consumer downgraded to Neutral from Buy at DA Davidson
06/29/20 Sidoti
Prestige Consumer upgraded to Buy from Neutral at Sidoti
04/15/20 DA Davidson
Prestige Consumer price target raised to $47 from $43 at DA Davidson
PBH Prestige Consumer
$43.52 /

+0.93 (+2.18%)

Conference/Events
InfuSystem participates in a conference call hosted by Lake Street » 04:55
03/08/21
03/08
04:55
03/08/21
04:55
INFU

InfuSystem

$17.40 /

+0.07 (+0.40%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INFU InfuSystem
$17.40 /

+0.07 (+0.40%)

INFU InfuSystem
$17.40 /

+0.07 (+0.40%)

12/29/20 Sidoti
InfuSystem initiated with a Buy at Sidoti
08/31/20
Fly Intel: Top five analyst initiations
08/31/20 Craig-Hallum
InfuSystem initiated with a Buy at Craig-Hallum
06/09/20 Lake Street
InfuSystem initiated with a Buy at Lake Street
INFU InfuSystem
$17.40 /

+0.07 (+0.40%)

Conference/Events
James River Group management to meet virtually with JMP Securities » 04:55
03/08/21
03/08
04:55
03/08/21
04:55
JRVR

James River Group

$46.83 /

-0.19 (-0.40%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JRVR James River Group
$46.83 /

-0.19 (-0.40%)

JRVR James River Group
$46.83 /

-0.19 (-0.40%)

01/06/21 Compass Point
James River Group price target raised to $69 from $56 at Compass Point
11/02/20 Compass Point
James River Group upgraded to Buy from Neutral at Compass Point
10/29/20 B. Riley Securities
James River Group price target raised to $65 from $60 at B. Riley Securities
09/18/20 Compass Point
Compass Point starts James River Group at Neutral amid transition
JRVR James River Group
$46.83 /

-0.19 (-0.40%)

JRVR James River Group
$46.83 /

-0.19 (-0.40%)

Conference/Events
Itron management to meet virtually with Stephens » 04:55
03/08/21
03/08
04:55
03/08/21
04:55
ITRI

Itron

$110.62 /

-4.345 (-3.78%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITRI Itron
$110.62 /

-4.345 (-3.78%)

ITRI Itron
$110.62 /

-4.345 (-3.78%)

03/03/21 Argus
Itron upgraded to Buy from Hold at Argus
03/03/21 Argus
Itron upgraded to Buy from Hold at Argus
02/25/21 Oppenheimer
Itron price target raised to $127 from $75 at Oppenheimer
01/08/21 Raymond James
Itron downgraded to Outperform from Strong Buy at Raymond James
ITRI Itron
$110.62 /

-4.345 (-3.78%)

Conference/Events
Cantor Fitzgerald biopharma analysts hold an analyst/industry conference call » 04:55
03/08/21
03/08
04:55
03/08/21
04:55
ADVM

Adverum Biotechnologies

$11.12 /

+0.13 (+1.18%)

, UBX

Unity Biotechnology

$6.17 /

-0.58 (-8.59%)

, AGTC

Applied Genetic

$4.89 /

-0.16 (-3.17%)

, JNJ

Johnson & Johnson

$156.09 /

+3.09 (+2.02%)

, MGTX

MeiraGTx

$14.54 /

+0.6 (+4.30%)

, NITE

Nightstar Therapeutics

$25.41 /

+ (+0.00%)

, BIIB

Biogen

$270.57 /

+7.08 (+2.69%)

, AERI

Aerie Pharmaceuticals

$18.78 /

-0.42 (-2.19%)

, ALDX

Aldeyra

$11.17 /

+0.01 (+0.09%)

Biopharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADVM Adverum Biotechnologies
$11.12 /

+0.13 (+1.18%)

UBX Unity Biotechnology
$6.17 /

-0.58 (-8.59%)

AGTC Applied Genetic
$4.89 /

-0.16 (-3.17%)

JNJ Johnson & Johnson
$156.09 /

+3.09 (+2.02%)

MGTX MeiraGTx
$14.54 /

+0.6 (+4.30%)

BIIB Biogen
$270.57 /

+7.08 (+2.69%)

AERI Aerie Pharmaceuticals
$18.78 /

-0.42 (-2.19%)

ALDX Aldeyra
$11.17 /

+0.01 (+0.09%)

ADVM Adverum Biotechnologies
$11.12 /

+0.13 (+1.18%)

12/15/20 UBS
Adverum Biotechnologies initiated with a Neutral at UBS
11/15/20 Piper Sandler
Adverum Biotechnologies shares should grind higher over time, says Piper Sandler
11/12/20 Raymond James
Adverum Biotechnologies upgraded to Market Perform from Underperform at Raymond James
11/12/20 Raymond James
Adverum Biotechnologies upgraded to Market Perform at Raymond James
UBX Unity Biotechnology
$6.17 /

-0.58 (-8.59%)

02/16/21 Citi
Unity Biotechnology downgraded to Sell from Neutral at Citi
08/18/20
Fly Intel: Top five analyst downgrades
08/18/20 Morgan Stanley
Unity Biotechnology downgraded at Morgan Stanley as UBX101 doesn't meet endpoint
08/18/20 Citi
Unity Biotechnology downgraded to Neutral from Buy at Citi
AGTC Applied Genetic
$4.89 /

-0.16 (-3.17%)

03/01/21 Stifel
Applied Genetic initiated with a Buy at Stifel
02/02/21 H.C. Wainwright
Applied Genetic price target raised to $24 from $18 at H.C. Wainwright
02/01/21 Roth Capital
Applied Genetic price target raised to $35 from $30 at Roth Capital
11/17/20 Roth Capital
Applied Genetic price target raised to $30 from $26 at Roth Capital
JNJ Johnson & Johnson
$156.09 /

+3.09 (+2.02%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
MGTX MeiraGTx
$14.54 /

+0.6 (+4.30%)

02/16/21 Chardan
MeiraGTx called a Top Pick for 2021 at Chardan
12/17/20 Chardan
Chardan boosts MeiraGTx target to $55, say buy shares 'now'
12/17/20 Piper Sandler
Piper says MeiraGTx not getting credit for RIX gene therapy that 'clearly works'
10/22/20 RBC Capital
MeiraGTx initiated with an Outperform at RBC Capital
NITE Nightstar Therapeutics
$25.41 /

+ (+0.00%)

BIIB Biogen
$270.57 /

+7.08 (+2.69%)

02/17/21 Cantor Fitzgerald
Biogen price target lowered to $268 from $278 at Cantor Fitzgerald
02/08/21 Citi
Expert sees Biogen aducanumab approval 50/50 at best, says Citi
02/04/21 SVB Leerink
Biogen price target lowered to $380 from $430 at SVB Leerink
02/04/21 Credit Suisse
Biogen price target lowered to $338 from $350 at Credit Suisse
AERI Aerie Pharmaceuticals
$18.78 /

-0.42 (-2.19%)

11/09/20 H.C. Wainwright
Aerie Pharmaceuticals price target lowered to $29 from $31 at H.C. Wainwright
10/28/20 H.C. Wainwright
Aerie Pharmaceuticals $50M upfront should reduce overhang, says H.C. Wainwright
10/19/20 BofA
Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
10/19/20 BofA
Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
ALDX Aldeyra
$11.17 /

+0.01 (+0.09%)

02/08/21 H.C. Wainwright
Aldeyra initiated with a Buy at H.C. Wainwright
01/28/21 JonesTrading
Aldeyra assumed with a Buy at JonesTrading
01/08/21 Jefferies
Aldeyra could double if topline of TRANQUILITY study positive, says Jefferies
01/08/21 Citi
Aldeyra shares have 'plenty of upside' despite 26% rally, says Citi
ADVM Adverum Biotechnologies
$11.12 /

+0.13 (+1.18%)

UBX Unity Biotechnology
$6.17 /

-0.58 (-8.59%)

AGTC Applied Genetic
$4.89 /

-0.16 (-3.17%)

JNJ Johnson & Johnson
$156.09 /

+3.09 (+2.02%)

MGTX MeiraGTx
$14.54 /

+0.6 (+4.30%)

BIIB Biogen
$270.57 /

+7.08 (+2.69%)

AERI Aerie Pharmaceuticals
$18.78 /

-0.42 (-2.19%)

ALDX Aldeyra
$11.17 /

+0.01 (+0.09%)

  • 28
    Jan
  • 14
    Jan
  • 19
    Nov
  • 13
    Aug
JNJ Johnson & Johnson
$156.09 /

+3.09 (+2.02%)

BIIB Biogen
$270.57 /

+7.08 (+2.69%)

UBX Unity Biotechnology
$6.17 /

-0.58 (-8.59%)

AGTC Applied Genetic
$4.89 /

-0.16 (-3.17%)

JNJ Johnson & Johnson
$156.09 /

+3.09 (+2.02%)

BIIB Biogen
$270.57 /

+7.08 (+2.69%)

AERI Aerie Pharmaceuticals
$18.78 /

-0.42 (-2.19%)

ALDX Aldeyra
$11.17 /

+0.01 (+0.09%)

BIIB Biogen
$270.57 /

+7.08 (+2.69%)

JNJ Johnson & Johnson
$156.09 /

+3.09 (+2.02%)

BIIB Biogen
$270.57 /

+7.08 (+2.69%)

Conference/Events
Pinnacle West management to meet virtually with Mizuho » 04:55
03/08/21
03/08
04:55
03/08/21
04:55
PNW

Pinnacle West

$76.36 /

+1.71 (+2.29%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PNW Pinnacle West
$76.36 /

+1.71 (+2.29%)

PNW Pinnacle West
$76.36 /

+1.71 (+2.29%)

02/25/21 Credit Suisse
Pinnacle West downgraded to Neutral from Outperform at Credit Suisse
01/19/21 Credit Suisse
Pinnacle West price target lowered to $86 from $92 at Credit Suisse
01/06/21 Wells Fargo
Wells Fargo says buy CenterPoint Energy, sell FirstEnergy
11/18/20 Barclays
Pinnacle West price target raised to $103 from $89 at Barclays
PNW Pinnacle West
$76.36 /

+1.71 (+2.29%)

PNW Pinnacle West
$76.36 /

+1.71 (+2.29%)

PNW Pinnacle West
$76.36 /

+1.71 (+2.29%)

Upgrade
Amneal Pharmaceuticals upgraded to Buy from Sell at Goldman Sachs » 04:54
03/08/21
03/08
04:54
03/08/21
04:54
AMRX

Amneal Pharmaceuticals

$4.95 /

+0.13 (+2.70%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMRX Amneal Pharmaceuticals
$4.95 /

+0.13 (+2.70%)

AMRX Amneal Pharmaceuticals
$4.95 /

+0.13 (+2.70%)

03/01/21 Barclays
Amneal Pharmaceuticals price target raised to $8 from $6 at Barclays
12/14/20 Guggenheim
Amneal Pharmaceuticals upgraded to Buy from Neutral at Guggenheim
12/14/20 Barclays
Amneal upgraded to Overweight on generic recovery at Barclays
12/14/20 Barclays
Amneal upgraded to Overweight from Equal Weight at Barclays
AMRX Amneal Pharmaceuticals
$4.95 /

+0.13 (+2.70%)

Downgrade
Viatris downgraded to Neutral from Buy at Goldman Sachs » 04:52
03/08/21
03/08
04:52
03/08/21
04:52
VTRS

Viatris

$13.91 /

+0.31 (+2.28%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VTRS Viatris
$13.91 /

+0.31 (+2.28%)

VTRS Viatris
$13.91 /

+0.31 (+2.28%)

03/02/21 JPMorgan
Viatris downgraded to Neutral on 'modest' growth at JPMorgan
03/02/21 JPMorgan
Viatris downgraded to Neutral from Overweight at JPMorgan
02/26/21 Wolfe Research
Viatris downgraded to Peer Perform from Outperform at Wolfe Research
02/23/21 Barclays
Viatris price target lowered to $20 from $26 at Barclays
VTRS Viatris
$13.91 /

+0.31 (+2.28%)

VTRS Viatris
$13.91 /

+0.31 (+2.28%)

Initiation
Signify Health initiated with an Overweight at Piper Sandler » 04:50
03/08/21
03/08
04:50
03/08/21
04:50
SGFY

Signify Health

$28.30 /

+0.57 (+2.06%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
  • 11
    Feb
SGFY Signify Health
$28.30 /

+0.57 (+2.06%)

SGFY Signify Health
$28.30 /

+0.57 (+2.06%)

Initiation
Apria initiated with an Overweight at Piper Sandler » 04:48
03/08/21
03/08
04:48
03/08/21
04:48
APR

Apria

$21.49 /

-0.41 (-1.87%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APR Apria
$21.49 /

-0.41 (-1.87%)

  • 11
    Feb
APR Apria
$21.49 /

-0.41 (-1.87%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.